Does PAZOPANIB Cause Concomitant disease aggravated? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Concomitant disease aggravated have been filed in association with PAZOPANIB (Pazopanib). This represents 0.2% of all adverse event reports for PAZOPANIB.
42
Reports of Concomitant disease aggravated with PAZOPANIB
0.2%
of all PAZOPANIB reports
12
Deaths
19
Hospitalizations
How Dangerous Is Concomitant disease aggravated From PAZOPANIB?
Of the 42 reports, 12 (28.6%) resulted in death, 19 (45.2%) required hospitalization, and 2 (4.8%) were considered life-threatening.
Is Concomitant disease aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PAZOPANIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does PAZOPANIB Cause?
Death (3,767)
Diarrhoea (2,907)
Fatigue (1,883)
Nausea (1,879)
Malignant neoplasm progression (1,471)
Drug ineffective (1,135)
Decreased appetite (1,116)
Vomiting (1,072)
Hypertension (1,004)
Malaise (764)
What Other Drugs Cause Concomitant disease aggravated?
SACUBITRIL\VALSARTAN (533)
SECUKINUMAB (461)
FINGOLIMOD (425)
MACITENTAN (286)
OMALIZUMAB (186)
SELEXIPAG (166)
METHOTREXATE (150)
RUXOLITINIB (142)
OCTREOTIDE (125)
BOSENTAN (123)
Which PAZOPANIB Alternatives Have Lower Concomitant disease aggravated Risk?
PAZOPANIB vs PEANUT
PAZOPANIB vs PEG INTERFERON
PAZOPANIB vs PEG-INTERFERON ALFA 2A
PAZOPANIB vs PEGASPARGASE
PAZOPANIB vs PEGASYS